CLINICIAN INSIGHT BRIEF
This Clinical Insight Brief is a summary and presentation of findings from interviews with 25 European cardiac surgeons regarding their current practices, caseload and perspectives in the performance of coronary artery bypass grafting (CABG), as well as their opinions on emerging practices and technologies for CABG including the use of off-pump (also known as "beating heart") bypass, minimally invasive direct coronary artery bypass (MIDCAB) and the specific products available or under development by manufacturers for these purposes. Direct phone interviews were held with cardiac surgeons in August/September 2004.
Selected Survey Questions*
1. In what country do you currently practice medicine?
2. How many years have you been in practice?
3. What is your current caseload per month in the performance of coronary artery bypass grafting?
4. What is your current bypass caseload split between on-pump and off-pump?
5. What percentage of your current bypass caseload is done via minimally invasive direct coronary artery bypass graft? __%
6. If you expect to be performing bypass in two years, what is your expected caseload split for on/off-pump?
7. What is the likely impact over the next year of drug-eluting stents on your bypass caseload?
8. What products (stabilizers, positioners, anastomosis connectors) do you currently use and why?
9. What newly introduced products for CABG do you expect to increasingly use over the next two years?__________
10. What needs do you see for product development in OPCAB? ___________
11. What needs do you see for product development otherwise to improve outcomes in bypass?____________
12. To what degree do you believe that OPCAB reduces neurological deficits and pump sickness? _____________
13. Please provide us with us with a brief statement about off-pump bypass and where you see its potential, consideration of alternative treatments (e.g., drug-eluting stents) for coronary artery disease, limitations in off-pumpís use to specific patient types or other factors driving or limiting off-pump use procedure volume.
* Interviews followed a basic script at a minimum, but actual interviews were wide ranging depending upon surgeon responses and willingness to provide additional detail.
Why Buy This Report
∑ Reveals shifts in OPCAB practice patterns limiting and creating opportunities for manufacturers
∑ Identifies manufacturer strengths and weaknesses
∑ Reveals new product opportunities driven by clinician demand
CLINICIAN INSIGHT BRIEF
Price: $395 for print or PDF; $495 for both. -- Add $150 for site license [what's this?]
Contact: Patrick Driscoll, (949) 859-3401.
Copyright © 2006 MedMarket Diligence, LLC. All rights reserved.
MedMarket Diligence Reports